pembrolizumab,n-803
merck,immunitybio
['bladder', 'pembrolizumab']
data close to those observed with #pembrolizumab which seem that immunomodulation is the way to avoid surgery in these high-risk tumors american society of clinical oncology (asco) #asco2022 #day1 #bladdercancer 
Medical Oncologist, Urologic Oncology. Running Addict.@CHRU_Brest